Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

TDF and quantitative ultrasound bone quality in African patients on second line ART, ANRS 12169 2LADY sub-study.

Kabore FN, Eymard-Duvernay S, Zoungrana J, Badiou S, Bado G, Héma A, Diouf A, Delaporte E, Koulla-Shiro S, Ciaffi L, Cournil A.

PLoS One. 2017 Nov 8;12(11):e0186686. doi: 10.1371/journal.pone.0186686. eCollection 2017.

2.

[Prevalence of hepatitis B surface antigen and its associated factors in Senegalese military personnel sent on mission to Darfur].

Diop M, Diouf A, Seck SM, Lo G, Ka D, Massaly A, Dieye A, Fall NM, Cisse-Diallo VMP, Diallo-Mbaye K, Lakhe NA, Fortes-Déguénonvo L, Ndour CT, Soumaré M, Seydi M.

Pan Afr Med J. 2017 Mar 15;26:154. doi: 10.11604/pamj.2017.26.154.11594. eCollection 2017. French.

3.

Evolution of renal function in African patients initiating second-line antiretroviral treatment: findings from the ANRS 12169 2LADY trial.

Cournil A, Hema A, Eymard-Duvernay S, Ciaffi L, Badiou S, Kabore FN, Diouf A, Ayangma L, Le Moing V, Reynes J, Koulla-Shiro S, Delaporte E; 2LADY Study Group.

Antivir Ther. 2017;22(3):195-203. doi: 10.3851/IMP3097. Epub 2016 Oct 5.

PMID:
27705950
4.

Nutritional status of HIV-infected patients during the first year HAART in two West African cohorts.

Sicotte M, Bemeur C, Diouf A, Zunzunegui MV, Nguyen VK; ATARAO initiative.

J Health Popul Nutr. 2015 May 1;34:1. doi: 10.1186/s41043-015-0001-5.

5.

Impact of variability in adherence to HIV antiretroviral therapy on the immunovirological response and mortality.

Boussari O, Subtil F, Genolini C, Bastard M, Iwaz J, Fonton N, Etard JF, Ecochard R; ANRS 1215 study group.

BMC Med Res Methodol. 2015 Feb 5;15:10. doi: 10.1186/1471-2288-15-10.

6.

Development of a checklist of quality indicators for clinical trials in resource-limited countries: the French National Agency for Research on AIDS and Viral Hepatitis (ANRS) experience.

Hanna M, Minga A, Fao P, Borand L, Diouf A, Mben JM, Gad RR, Anglaret X, Bazin B, Chene G; [Quali-PED] ANRS 12175 Study Group.

Clin Trials. 2013 Apr;10(2):300-18. doi: 10.1177/1740774512470765. Epub 2013 Jan 23.

PMID:
23345311
7.

Risk of virological failure and drug resistance during first and second-line antiretroviral therapy in a 10-year cohort in Senegal: results from the ANRS 1215 cohort.

De Beaudrap P, Thiam M, Diouf A, Toure-Kane C, Ngom-Guèye NF, Vidal N, Mboup S, Ndoye I, Sow PS, Delaporte E; ANRS 1215 Study Group.

J Acquir Immune Defic Syndr. 2013 Apr 1;62(4):381-7. doi: 10.1097/QAI.0b013e31827a2a7a.

PMID:
23117504
8.

Reduced quantitative ultrasound bone mineral density in HIV-infected patients on antiretroviral therapy in Senegal.

Cournil A, Eymard-Duvernay S, Diouf A, Moquet C, Coutherut J, Ngom Gueye NF, Cames C, Taverne B, Bork K, Sow PS, Delaporte E; ANRS 1215 Study Group.

PLoS One. 2012;7(2):e31726. doi: 10.1371/journal.pone.0031726. Epub 2012 Feb 16.

9.

Diabetes and Hypertension among Patients Receiving Antiretroviral Treatment Since 1998 in Senegal: Prevalence and Associated Factors.

Diouf A, Cournil A, Ba-Fall K, Ngom-Guèye NF, Eymard-Duvernay S, Ndiaye I, Batista G, Guèye PM, Bâ PS, Taverne B, Delaporte E, Sow PS.

ISRN AIDS. 2012 Dec 1;2012:621565. doi: 10.5402/2012/621565. eCollection 2012.

10.

The development of PROQOL-HIV: an international instrument to assess the health-related quality of life of persons living with HIV/AIDS.

Duracinsky M, Herrmann S, Berzins B, Armstrong AR, Kohli R, Le Coeur S, Diouf A, Fournier I, Schechter M, Chassany O.

J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):498-505. doi: 10.1097/QAI.0b013e318245cafe.

PMID:
22205438
11.

Long-term effectiveness and safety of didanosine combined with lamivudine and efavirenz or nevirapine in antiretroviral-naive patients: a 9-year cohort study in Senegal.

Laurent C, Tchatchueng Mbougua JB, Ngom Guèye NF, Etard JF, Diouf A, Landman R, Molinari N, Girard PM, Sow PS, Ndoye I, Delaporte E; ANRS 1215/1290 Study Group.

Trop Med Int Health. 2011 Feb;16(2):217-22. doi: 10.1111/j.1365-3156.2010.02690.x. Epub 2010 Nov 19.

12.

Changes in the renal function after tenofovir-containing antiretroviral therapy initiation in a Senegalese cohort (ANRS 1215).

De Beaudrap P, Diallo MB, Landman R, Guèye NF, Ndiaye I, Diouf A, Kane CT, Etard JF, Girard PM, Sow PS, Delaporte E; ANRS 1215 Study Group.

AIDS Res Hum Retroviruses. 2010 Nov;26(11):1221-7. doi: 10.1089/aid.2009.0261. Epub 2010 Sep 21.

PMID:
20854202
13.

Incidence and determinants of new AIDS-defining illnesses after HAART initiation in a Senegalese cohort.

De Beaudrap P, Etard JF, Diouf A, Ndiaye I, Ndèye GF, Sow PS, Ndèye KC, Ecochard R, Delaporte E; ANRS 1215 Study Group.

BMC Infect Dis. 2010 Jun 19;10:179. doi: 10.1186/1471-2334-10-179.

14.

Short and Long-Term Incidence of Tuberculosis and CD4-Cell Count Dynamic on HAART in Senegal.

Etard JF, Diouf A, De Beaudrap P, Akoi K, Ngom-Guèye NF, Ndiaye I, Ecochard R, Sow PS, Eric D.

Open AIDS J. 2009 Dec 31;3:63-70. doi: 10.2174/1874613600903010063.

15.

Modeling CD4+ cell count increase over a six-year period in HIV-1-infected patients on highly active antiretroviral therapy in Senegal.

De Beaudrap P, Etard JF, Diouf A, Ndiaye I, Guèye NF, Guèye PM, Sow PS, Mboup S, Ndoye I, Ecochard R, Eric D; ANRS 1215/90 Study Group.

Am J Trop Med Hyg. 2009 Jun;80(6):1047-53.

PMID:
19478274
16.

Change over time of mortality predictors after HAART initiation in a Senegalese cohort.

De Beaudrap P, Etard JF, Ecochard R, Diouf A, Dieng AB, Cilote V, Ndiaye I, Guèye NF, Guèye PM, Sow PS, Mboup S, Ndoye I, Delaporte E.

Eur J Epidemiol. 2008;23(3):227-34. doi: 10.1007/s10654-007-9221-3. Epub 2008 Jan 16.

PMID:
18197359
17.

Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.

Etard JF, Ndiaye I, Thierry-Mieg M, Guèye NF, Guèye PM, Lanièce I, Dieng AB, Diouf A, Laurent C, Mboup S, Sow PS, Delaporte E.

AIDS. 2006 May 12;20(8):1181-9.

PMID:
16691070

Supplemental Content

Loading ...
Support Center